IL2 and neoplasm: Although mice injected with high viral titers (1012 rAAV IL-2) died within 2 weeks, mice injected with lower titer (109–1011 rAAV-IL-2) lived normal life spans with unaffected vaccine-mediated antibody responses, infection-induced immune responses, and notably, not-enhanced tumor growth (71).